Article info
PDFClinical science
Results of 2 years of treatment with as-needed ranibizumab reinjection for polypoidal choroidal vasculopathy
- Correspondence to Dr Taiichi Hikichi, Department of Ophthalmology, Ohtsuka Eye Hospital, Kita-16 Nishi-4, Kita-ku, Sapporo 001-0016, Japan; taiichi-hikichi{at}hokkaido.med.or.jp
Citation
Results of 2 years of treatment with as-needed ranibizumab reinjection for polypoidal choroidal vasculopathy
Publication history
- Received September 25, 2012
- Revised January 14, 2013
- Accepted January 21, 2013
- First published February 21, 2013.
Online issue publication
July 30, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/3.0/ and http://creativecommons.org/licenses/by-nc/3.0/legalcode